Lyra Therapeutics Inc Forecast, price target & analysts
Lyra Therapeutics Inc Target price 2024 - Analyst rating & recommendation
Lyra Therapeutics Inc Classifications & Recommendation:
Lyra Therapeutics Inc Target price
| Target price | $1.25 |
| Course | $0.28 |
| Price potential |
351.75%
register free of charge
|
| Number of estimates | 2 |
|
2 Analysts have issued a price target Lyra Therapeutics Inc 2025 .
The average Lyra Therapeutics Inc target price is $1.25.
This is
351.75%
register free of charge
$2.00
622.80%
register free of charge
$0.50
80.70%
register free of charge
|
|
| A rating was issued by 5 analysts: 1 Analysts recommend Lyra Therapeutics Inc to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst estimates: Analysts believe that the Lyra Therapeutics Inc share has an average upside potential 2025 of
351.75%
register free of charge
|
Sales and margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Turnover Million $ | 1.56 | 1.59 |
| 14.71% | 1.64% | |
| Net margin | -4,923.69% | -4,459.74% |
| 39.97% | 9.42% |
5 Analysts have issued a sales forecast Lyra Therapeutics Inc 2024 . The average Lyra Therapeutics Inc sales estimate is
This results in the following potential growth figures:
1 Analyst has issued a net profit forecast Lyra Therapeutics Inc 2024 . The average Lyra Therapeutics Inc net profit estimate is
This results in the following potential growth figures and future net margins:
Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Earnings per share $ | -1.26 | -1.16 |
| 31.15% | 7.94% | |
| P/E ratio | negative | |
| EV/Sales | negative |
1 Analysts have issued a Lyra Therapeutics Inc forecast for earnings per share. The average Lyra Therapeutics Inc <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Based on analysts' sales estimates for 2024, the Lyra Therapeutics Inc share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
This results in the following potential growth figures and future valuations:
Lyra Therapeutics Inc...
Discover more stocks with a high price target
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.
